Cargando…
Anti-atherogenic effects of fibrates in type 2 diabetes
Type 2 diabetes is an increasing cause of premature coronary heart disease. Several trials with lipid-modifying therapy have included sufficient numbers of diabetics to indicate that treatment of diabetic dyslipidaemia with either fibrates or statins reduces the risk of future coronary events in suc...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59525/ https://www.ncbi.nlm.nih.gov/pubmed/11806800 http://dx.doi.org/10.1186/cvm-2-5-218 |